• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种经济有效的定量内部 ELISA 检测法,用于筛选针对 SARS-CoV-2 的 S1 抗体。

Development of a cost-effective quantitative in-house ELISA assay for screening anti-S1 IgG antibodies targeting SARS-CoV-2.

机构信息

Medical Microbiology Department, College of Medicine, Al-Nahrain University, Baghdad, Iraq.

Basic and Medical Sciences Branch, College of Nursing, University of Al-Ameed, Karbala, Iraq.

出版信息

J Med Life. 2023 Jun;16(6):883-889. doi: 10.25122/jml-2023-0047.

DOI:10.25122/jml-2023-0047
PMID:37675173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10478653/
Abstract

The RBD, S, and N proteins, the three main antigens of the SARS-CoV-2 virus, activate the host immune system and cause the formation of IgM and IgG antibodies. While IgM indicates an early, acute infection stage, IgG shows a past infection or persistent sickness. This study used an indirect ELISA assay that targets the S1 subunit of the SARS-CoV-2 S protein to create an in-house, qualitative serological test specific to COVID-19. A total of 60 serum samples were examined using ELISA for anti-SARS-CoV-2 IgG, and 50 of those results were positive. An additional 20 samples were taken from cases that occurred before the pandemic. For the in-house ELISA assay, a plasmid containing the gene coding for the S1 subunit was transformed into DH5ɑ bacterial cells and the protein was synthesized and purified. The purified protein was utilized to coat the ELISA plate, which was subsequently used to assess the levels of IgG among individuals with SARS-CoV-2 infection. The study found a significant association (p-value=0.01) between the in-house and the commercial anti-S1 subunit IgG antibodies kits. The in-house ELISA responded well, with a sensitivity and specificity of 75.0% and 88.89%, respectively. Furthermore, a library of SARS-CoV-2 recombinant S1 subunits was created by competent bacteria and may be employed for various tasks, such as creating diagnostic tools and scientific investigation. Overall, the in-house anti-SARS-CoV-2 human IgG-ELISA proved to be sensitive and specific for identifying IgG antibodies in patients exposed to SARS-CoV-2.

摘要

SARS-CoV-2 病毒的三个主要抗原 RBD、S 和 N 蛋白激活宿主免疫系统,导致 IgM 和 IgG 抗体的形成。虽然 IgM 表明处于早期、急性感染阶段,但 IgG 表明过去感染或持续患病。本研究使用针对 SARS-CoV-2 S 蛋白 S1 亚单位的间接 ELISA 检测试剂盒,开发了一种针对 COVID-19 的内部定性血清学检测方法。共使用 ELISA 检测了 60 份血清样本中的抗 SARS-CoV-2 IgG,其中 50 份结果为阳性。另外还从大流行前的病例中采集了 20 个样本。对于内部 ELISA 检测,将含有编码 S1 亚单位的基因的质粒转化到 DH5ɑ 细菌细胞中,并合成和纯化蛋白质。将纯化的蛋白质用于包被 ELISA 板,然后使用该板来评估具有 SARS-CoV-2 感染的个体中的 IgG 水平。研究发现内部 ELISA 与商业抗 S1 亚单位 IgG 抗体试剂盒之间存在显著关联(p 值=0.01)。内部 ELISA 反应良好,灵敏度和特异性分别为 75.0%和 88.89%。此外,通过感受态细菌创建了 SARS-CoV-2 重组 S1 亚单位文库,可用于创建诊断工具和科学研究等各种任务。总体而言,内部 SARS-CoV-2 人类 IgG-ELISA 被证明在识别接触过 SARS-CoV-2 的患者的 IgG 抗体方面具有敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/af1650268e3d/JMedLife-16-883-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/70a23057145b/JMedLife-16-883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/b0cc00c3e427/JMedLife-16-883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/0874e2972891/JMedLife-16-883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/af1650268e3d/JMedLife-16-883-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/70a23057145b/JMedLife-16-883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/b0cc00c3e427/JMedLife-16-883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/0874e2972891/JMedLife-16-883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60be/10478653/af1650268e3d/JMedLife-16-883-g004.jpg

相似文献

1
Development of a cost-effective quantitative in-house ELISA assay for screening anti-S1 IgG antibodies targeting SARS-CoV-2.开发一种经济有效的定量内部 ELISA 检测法,用于筛选针对 SARS-CoV-2 的 S1 抗体。
J Med Life. 2023 Jun;16(6):883-889. doi: 10.25122/jml-2023-0047.
2
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers.基于受体结合域的 ELISA 和 Luminex 预测德国和西班牙医护人员的两个纵向队列对 SARS-CoV-2 替代中和活性。
Microbiol Spectr. 2023 Feb 14;11(1):e0316522. doi: 10.1128/spectrum.03165-22. Epub 2023 Jan 9.
3
Performance estimation of two in-house ELISA assays for COVID-19 surveillance through the combined detection of anti-SARS-CoV-2 IgA, IgM, and IgG immunoglobulin isotypes.通过联合检测抗 SARS-CoV-2 IgA、IgM 和 IgG 免疫球蛋白亚型对两种用于 COVID-19 监测的内部 ELISA 检测方法进行性能评估。
PLoS One. 2023 Feb 6;18(2):e0270388. doi: 10.1371/journal.pone.0270388. eCollection 2023.
4
Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.市售 SARS-CoV-2 IgG ELISA 在非洲来源血清样本中的特异性有限。
Trop Med Int Health. 2021 Jun;26(6):621-631. doi: 10.1111/tmi.13569. Epub 2021 Apr 5.
5
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.临床实践中 SARS-CoV-2 抗体的血清学检测:一项比较诊断准确性研究。
Allergy. 2022 Jul;77(7):2090-2103. doi: 10.1111/all.15206. Epub 2022 Jan 11.
6
Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.弥补 COVID-19 诊断检测中的血清学差距:抗 SARS-CoV-2 IgA 抗体的价值。
J Med Virol. 2021 Mar;93(3):1436-1442. doi: 10.1002/jmv.26422. Epub 2020 Aug 21.
7
Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.酶联免疫吸附试验评价 COVID-19 患者血清 IgM 和 IgG 抗体。
J Med Virol. 2021 May;93(5):2857-2866. doi: 10.1002/jmv.26741. Epub 2021 Mar 1.
8
Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.采用两种血清学检测方法对 SARS-CoV-2 感染进行筛查。
Niger J Physiol Sci. 2020 Dec 31;35(2):117-121.
9
Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.六种市售 SARS-CoV-2 抗体检测试剂盒的比较——检测试剂盒的选择取决于预期用途。
Int J Infect Dis. 2021 Feb;103:381-388. doi: 10.1016/j.ijid.2020.12.017. Epub 2020 Dec 10.
10
Quantitative Detection of Anti-SARS-CoV-2 Antibodies Using Indirect ELISA.采用间接 ELISA 法定量检测抗 SARS-CoV-2 抗体。
Lab Med. 2022 May 5;53(3):225-234. doi: 10.1093/labmed/lmab085.

引用本文的文献

1
Case Report: Positive IgM does not necessarily indicate acute infection: two case studies.病例报告:IgM阳性不一定意味着急性感染:两项病例研究。
Front Pediatr. 2025 May 30;13:1520021. doi: 10.3389/fped.2025.1520021. eCollection 2025.
2
Rapid-Test Kit for Cardiac Troponin I: A Reliable Enzyme-Linked-Immuno-Substrate-Assay-Based Biosensor for Daily-Use Naked-Eye Detection and Pharmacokinetic Studies for Myocardial Infarction in Cardiovascular Disease.心肌肌钙蛋白I快速检测试剂盒:一种基于酶联免疫底物测定的可靠生物传感器,用于心血管疾病中急性心肌梗死的日常裸眼检测和药代动力学研究。
ACS Pharmacol Transl Sci. 2024 Jul 15;7(8):2369-2378. doi: 10.1021/acsptsci.4c00218. eCollection 2024 Aug 9.

本文引用的文献

1
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections.用于检测 SARS-CoV-2 感染的敏感且特异的血清学 ELISA 方法。
Virol J. 2022 Mar 19;19(1):50. doi: 10.1186/s12985-022-01768-4.
2
The relationship between IgG and IgM levels and severity of symptoms in COVID-19 patients confirmed by rapid antigen test.快速抗原检测确诊的 COVID-19 患者 IgG 和 IgM 水平与症状严重程度的关系。
J Med Life. 2021 Nov-Dec;14(6):790-796. doi: 10.25122/jml-2021-0194.
3
Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama.
巴拿马 COVID-19 患者中 SARS-CoV-2 刺突蛋白相关血清学的内部间接 ELISA 的开发。
PLoS One. 2021 Sep 14;16(9):e0257351. doi: 10.1371/journal.pone.0257351. eCollection 2021.
4
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG.一种基于新型刺突(S)蛋白的商业免疫测定法检测抗SARS-CoV-2 IgG的评估
Microorganisms. 2021 Mar 31;9(4):733. doi: 10.3390/microorganisms9040733.
5
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses.新冠病毒抗体反应的表位解析分析确定了与地方性人类冠状病毒的交叉反应性。
Cell Rep Med. 2021 Jan 19;2(1):100189. doi: 10.1016/j.xcrm.2020.100189.
6
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies.一种用于检测新型冠状病毒刺突蛋白特异性抗体的间接酶联免疫吸附测定法的开发与特性分析
J Immunol Methods. 2021 Mar;490:112958. doi: 10.1016/j.jim.2021.112958. Epub 2021 Jan 4.
7
Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia.急性寨卡病毒感染中使用 SARS-CoV-2 ELISA 检测的血清学交叉反应性,哥伦比亚。
Int J Infect Dis. 2020 Dec;101:191-193. doi: 10.1016/j.ijid.2020.09.1451. Epub 2020 Sep 28.
8
Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.采用两种商业免疫分析法分析 COVID-19 恢复期血浆中的 SARS-CoV-2 IgG。
J Immunol Methods. 2020 Nov;486:112837. doi: 10.1016/j.jim.2020.112837. Epub 2020 Aug 20.
9
SARS-CoV-2-specific ELISA development.SARS-CoV-2 特异性 ELISA 的开发。
J Immunol Methods. 2020 Sep-Oct;484-485:112832. doi: 10.1016/j.jim.2020.112832. Epub 2020 Aug 8.
10
Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape.用于 SARS-CoV-2 检测的诊断方法:美国食品药品监督管理局紧急使用授权 COVID-19 检测全景的综合回顾。
Biosens Bioelectron. 2020 Oct 1;165:112454. doi: 10.1016/j.bios.2020.112454. Epub 2020 Jul 18.